1. Home
  2. MEG vs FTRE Comparison

MEG vs FTRE Comparison

Compare MEG & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Montrose Environmental Group Inc.

MEG

Montrose Environmental Group Inc.

HOLD

Current Price

$22.14

Market Cap

930.8M

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$15.17

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEG
FTRE
Founded
2012
1996
Country
United States
United States
Employees
3500
N/A
Industry
Professional Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
930.8M
1.3B
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
MEG
FTRE
Price
$22.14
$15.17
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$35.25
$14.06
AVG Volume (30 Days)
266.4K
1.4M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
93.69
N/A
EPS
N/A
N/A
Revenue
$830,538,000.00
$2,723,400,000.00
Revenue This Year
$5.41
N/A
Revenue Next Year
$7.19
$3.09
P/E Ratio
N/A
N/A
Revenue Growth
19.26
1.00
52 Week Low
$19.38
$3.97
52 Week High
$32.00
$18.67

Technical Indicators

Market Signals
Indicator
MEG
FTRE
Relative Strength Index (RSI) 52.09 69.44
Support Level $20.80 $9.01
Resistance Level $23.48 $16.20
Average True Range (ATR) 0.79 0.72
MACD 0.13 -0.05
Stochastic Oscillator 88.92 87.01

Price Performance

Historical Comparison
MEG
FTRE

About MEG Montrose Environmental Group Inc.

Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits and permits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, and soil remediation. The company derives maximum revenue from United States.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.

Share on Social Networks: